Candel Therapeutics is a cutting-edge biotechnology company based in Newton, MA, dedicated to developing viral immunotherapies that harness the power of the immune system to combat cancer. Their innovative therapies are designed to provide personalized and long-lasting protection against cancer, tailored to each individual patient and their specific type of cancer.
With a strong focus on patient well-being, Candel Therapeutics aims to create viral immunotherapies that offer a favorable benefit-to-risk ratio, ensuring effective and well-tolerated treatments for patients at all stages of disease. Through their commitment to clinical trials and the advancement of off-the-shelf therapies, Candel Therapeutics is at the forefront of revolutionizing cancer treatment.
Generated from the website